BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weber B, Melchior W, Gehrke R, Doerr HW, Berger A, Rabenau H. Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol. 2001;64:312-319. [PMID: 11424120 DOI: 10.1002/jmv.1052] [Cited by in Crossref: 103] [Cited by in F6Publishing: 96] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Mortensen E, Kamali A, Schirmer PL, Lucero-Obusan C, Winston CA, Oda G, Winters MA, Durfee J, Martinello RA, Davey VJ, Holodniy M. Are current screening protocols for chronic hepatitis B virus infection adequate? Diagn Microbiol Infect Dis 2016;85:159-67. [PMID: 27009896 DOI: 10.1016/j.diagmicrobio.2015.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
2 Rodríguez-torres M, Gonzalez-garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-correa M, Depamphilis J, Torriani F; for the APRICOT investigators. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: Clinically relevant or a diagnostic problem? J Med Virol 2007;79:694-700. [DOI: 10.1002/jmv.20836] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
3 Haushofer AC, Hauer R, Brunner H, Köller U, Trubert-Exinger D, Halbmayer WM, Haas J, Kessler HH. Hepatitis B virus activity in patients with anti-hepatitis C virus antibody positivity and hepatitis B antigen positivity. J Clin Virol 2002;25 Suppl 3:S99-102. [PMID: 12467783 DOI: 10.1016/s1386-6532(02)00186-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Urbani S, Fagnoni F, Missale G, Franchini M. The role of anti-core antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med. 2010;48:23-29. [PMID: 19919328 DOI: 10.1515/cclm.2010.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
5 Aberg JA, Gallant JE, Anderson J, Oleske JM, Libman H, Currier JS, Stone VE, Kaplan JE. Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases 2004;39:609-29. [DOI: 10.1086/423390] [Cited by in Crossref: 114] [Cited by in F6Publishing: 96] [Article Influence: 6.7] [Reference Citation Analysis]
6 Pondé RA, Cardoso DD, Ferro MO. The underlying mechanisms for the 'anti-HBc alone' serological profile. Arch Virol 2010;155:149-58. [PMID: 20091193 DOI: 10.1007/s00705-009-0559-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
7 Hennig H, Puchta I, Luhm J, Schlenke P, Goerg S, Kirchner H. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood. 2002;100:2637-2641. [PMID: 12239179 DOI: 10.1182/blood-2002-03-0798] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 4.2] [Reference Citation Analysis]
8 Weber B, Van der Taelem-Brulé N, Berger A, Simon F, Geudin M, Ritter J. Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra. J Virol Methods. 2006;135:109-117. [PMID: 16567005 DOI: 10.1016/j.jviromet.2006.02.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
9 Lau DT, Hewlett AT. Screening for hepatitis A and B antibodies in patients with chronic liver disease. Am J Med. 2005;118 Suppl 10A:28S-33S. [PMID: 16271538 DOI: 10.1016/j.amjmed.2005.07.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
10 Zhang R, Wang L, Li J. Hepatitis B virus transfusion risk in China: proficiency testing for the detection of hepatitis B surface antigen. Transfus Med. 2010;20:322-328. [PMID: 20409073 DOI: 10.1111/j.1365-3148.2010.01007.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
11 Qi C, Zhu W, Niu Y, Zhang HG, Zhu GY, Meng YH, Chen S, Jin G. Detection of hepatitis B virus markers using a biosensor based on imaging ellipsometry. J Viral Hepat. 2009;16:822-832. [PMID: 19486471 DOI: 10.1111/j.1365-2893.2009.01123.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
12 Haushofer AC, Hauer R, Brunner H, Köller U, Trubert-exinger D, Halbmayer W, Koidl C, Kessler HH. No evidence of hepatitis B virus activity in patients with anti-HBc antibody positivity with or without anti-hepatitis C virus antibody positivity. Journal of Clinical Virology 2004;29:221-3. [DOI: 10.1016/s1386-6532(03)00156-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Weber B. Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol. 2006;78 Suppl 1:S59-S65. [PMID: 16622880 DOI: 10.1002/jmv.20610] [Cited by in Crossref: 50] [Cited by in F6Publishing: 56] [Article Influence: 3.3] [Reference Citation Analysis]
14 Powell EA, Razeghi S, Zucker S, Blackard JT. Occult Hepatitis B Virus Infection in a Previously Vaccinated Injection Drug User. Hepat Mon 2016;16:e34758. [PMID: 27148386 DOI: 10.5812/hepatmon.34758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
15 Koraka P, Burghoorn-Maas CP, Falconar A, Setiati TE, Djamiatun K, Groen J, Osterhaus AD. Detection of immune-complex-dissociated nonstructural-1 antigen in patients with acute dengue virus infections. J Clin Microbiol 2003;41:4154-9. [PMID: 12958240 DOI: 10.1128/JCM.41.9.4154-4159.2003] [Cited by in Crossref: 79] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
16 Elghannam DM, Aly RM, Goda EF, Eltoraby EE, Farag RE. Clinical significance of antibody to hepatitis B core antigen in multitransfused hemodialysis patients. Asian J Transfus Sci 2009;3:14-7. [PMID: 20041091 DOI: 10.4103/0973-6247.45256] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
17 Rodríguez-guardado A, Melón S, Rodríguez M, Asensi V, Cartón JA, de Oña M. Influence of HCV Genotype in Isolated Presence of Antibody to Hepatitis B Core Antigen in Patients With HIV Coinfection. JAIDS Journal of Acquired Immune Deficiency Syndromes 2006;42:647-9. [DOI: 10.1097/01.qai.0000223020.93944.f7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Zhou YH, Zhou J, Li L, Bi Y, Liu Y, Pan J, Wu C. A novel hepatitis B virus mutant coexisting with wild type virus in a carrier with negative HBsAg yet positive HBeAg and anti-HBs. J Clin Virol 2009;46:363-6. [PMID: 19782639 DOI: 10.1016/j.jcv.2009.09.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
19 Shim J, Kim KY, Kim BH, Chun H, Lee MS, Hwangbo Y, Jang JY, Dong SH, Kim HJ, Chang YW. Anti-hepatitis B core antibody is not required for prevaccination screening in healthcare workers. Vaccine. 2011;29:1721-1726. [PMID: 21147128 DOI: 10.1016/j.vaccine.2010.11.044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
20 Pereira AA, Jacobson IM. Modern diagnosis of HBV infection. Curr hepatitis rep 2009;8:18-25. [DOI: 10.1007/s11901-009-0003-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A, Khadem-Sadegh A, Velayati AA. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals. Int J STD AIDS. 2009;20:336-338. [PMID: 19386971 DOI: 10.1258/ijsa.2008.008377] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
22 Tsai PS, Chang CJ, Chen KT, Chang KC, Hung SF, Wang JH, Hung CH, Chen CH, Tseng PL, Kee KM, Yen YH, Tsai CC, Lu SN. Acquirement and disappearance of HBsAg and anti-HCV in an aged population: a follow-up study in an endemic township. Liver Int. 2011;31:971-979. [PMID: 21054768 DOI: 10.1111/j.1478-3231.2010.02363.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
23 Alzahrani FM, Muzaheed, Shaikh SS, Alomar AI, Acharya S, Elhadi N. Prevalence of Hepatitis B Virus (HBV) Among Blood Donors in Eastern Saudi Arabia: Results From a Five-Year Retrospective Study of HBV Seromarkers. Ann Lab Med 2019;39:81-5. [PMID: 30215234 DOI: 10.3343/alm.2019.39.1.81] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
24 Yang L, Song LW, Fang LL, Wu Y, Ge SX, Li H, Yuan Q, Zhang J, Xia NS. Evaluation of a novel chemiluminescent microplate enzyme immunoassay for hepatitis B surface antigen detection. J Virol Methods 2016;228:55-9. [PMID: 26615806 DOI: 10.1016/j.jviromet.2015.11.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
25 Guardado AR, P??rez MR, Maradona JA, Mart??nez A, Asensi V, Cart??n JA. Isolated Presence of Antibody to Hepatitis B Core Antigen in Patients Coinfected With HIV: . JAIDS Journal of Acquired Immune Deficiency Syndromes 2004;36:988-9. [DOI: 10.1097/00126334-200408010-00015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
26 Koene RPM, Gotz HM, Van Den Hoek JAR, Heijnen MLA, Van Steenbergen JA, Kroes ACM. Significance of isolated antibody to hepatitis B core antigen in Dutch national vaccination campaign of behavioural high-risk groups. Epidemiol Infect 2009;137:495-503. [DOI: 10.1017/s095026880800085x] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
27 Cremer J, Hofstraat SHI, van Heiningen F, Veldhuijzen IK, van Benthem BHB, Benschop KSM. Genetic variation of hepatitis B surface antigen among acute and chronic hepatitis B virus infections in The Netherlands. J Med Virol 2018;90:1576-85. [PMID: 29797607 DOI: 10.1002/jmv.25232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
28 Gutiérrez C, Devesa M, Loureiro CL, León G, Liprandi F, Pujol FH. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela. J Med Virol. 2004;73:200-207. [PMID: 15122793 DOI: 10.1002/jmv.20076] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis]
29 Weber B, Mühlbacher A, Melchior W. Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing. Journal of Clinical Virology 2005;32:67-70. [DOI: 10.1016/j.jcv.2004.09.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
30 Al-Rubaye A, Tariq Z, Alrubaiy L. Prevalence of hepatitis B seromarkers and hepatitis C antibodies in blood donors in Basra, Iraq. BMJ Open Gastroenterol 2016;3:e000067. [PMID: 26966550 DOI: 10.1136/bmjgast-2015-000067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Niederhauser C. Reducing the risk of hepatitis B virus transfusion-transmitted infection. J Blood Med 2011;2:91-102. [PMID: 22287868 DOI: 10.2147/JBM.S12899] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
32 Song JE, Kim DY. Diagnosis of hepatitis B. Ann Transl Med. 2016;4:338. [PMID: 27761442 DOI: 10.21037/atm.2016.09.11] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
33 Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang. 2004;86:83-91. [PMID: 15023176 DOI: 10.1111/j.0042-9007.2004.00406.x] [Cited by in Crossref: 192] [Cited by in F6Publishing: 183] [Article Influence: 11.3] [Reference Citation Analysis]
34 Rezaee R, Poorebrahim M, Najafi S, Sadeghi S, Pourdast A, Alavian SM, Alavian SE, Poortahmasebi V. Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational Analysis. Hepat Mon 2016;16:e39097. [PMID: 27642350 DOI: 10.5812/hepatmon.39097] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
35 Núñez M, Ríos P, Pérez-Olmeda M, Soriano V. Lack of 'occult' hepatitis B virus infection in HIV-infected patients. AIDS 2002;16:2099-101. [PMID: 12370518 DOI: 10.1097/00002030-200210180-00024] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 3.2] [Reference Citation Analysis]
36 Yu AS, Cheung RC, Keeffe EB. Hepatitis B vaccines. Clinics in Liver Disease 2004;8:283-300. [DOI: 10.1016/j.cld.2004.02.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
37 Weber B. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol. 2005;32:102-112. [PMID: 15653412 DOI: 10.1016/j.jcv.2004.10.008] [Cited by in Crossref: 140] [Cited by in F6Publishing: 123] [Article Influence: 8.8] [Reference Citation Analysis]
38 Ollier L, Laffont C, Kechkekian A, Doglio A, Giordanengo V. Detection of antibodies to hepatitis B core antigen using the Abbott ARCHITECT anti-HBc assay: analysis of borderline reactive sera. J Virol Methods. 2008;154:206-209. [PMID: 18848582 DOI: 10.1016/j.jviromet.2008.09.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
39 Kumari S. Prevalence and trends of hepatitis B virus, Hepatitis C virus, Human immunodeficiency virus 1, 2 and syphilis infections among blood donors in a regional transfusion center in Punjab, India: A 3 years study. Indian J Sex Transm Dis AIDS 2020;41:22-9. [PMID: 33062977 DOI: 10.4103/0253-7184.196887] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
40 Pallawela SN, Sonnex C, Mabayoje D, Bloch E, Chaytor S, Johnson MA, Carne C, Webster DP. Positive hepatitis B virus core antibody in HIV infection--false positive or evidence of previous infection? J Med Virol 2015;87:208-12. [PMID: 25174739 DOI: 10.1002/jmv.24048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
41 Hosokawa Y, Sano T. Scavenging of hydroxyl radicals generated in human plasma following X-ray irradiation. Radiation Protection Dosimetry 2015;167:326-30. [DOI: 10.1093/rpd/ncv272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
42 Banerjee A, Chandra PK, Datta S, Biswas A, Bhattacharya P, Chakraborty S, Chakrabarti S, Bhattacharya SK, Chakravarty R. Frequency and significance of hepatitis B virus surface gene variant circulating among ‘antiHBc only’ individuals in Eastern India. J Clin Virol. 2007;40:312-317. [PMID: 17997353 DOI: 10.1016/j.jcv.2007.08.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
43 Chen Y, Wu W, Li LJ, Lou B, Zhang J, Fan J. Comparison of the results for three automated immunoassay systems in determining serum HBV markers. Clin Chim Acta. 2006;372:129-133. [PMID: 16713592 DOI: 10.1016/j.cca.2006.03.032] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
44 Kamili S, Sozzi V, Thompson G, Campbell K, Walker CM, Locarnini S, Krawczynski K. Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model. Hepatology. 2009;49:1483-1491. [PMID: 19274751 DOI: 10.1002/hep.22796] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
45 Wu T, Kwok RM, Tran TT. Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues. Am J Gastroenterol 2017;112:1780-8. [PMID: 29087395 DOI: 10.1038/ajg.2017.397] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
46 Yu AS, Cheung RC, Keeffe EB. Hepatitis B vaccines. Infect Dis Clin North Am. 2006;20:27-45. [PMID: 16527647 DOI: 10.1016/j.idc.2006.01.004] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
47 Liu C, Chen D, Chen P. Epidemiology of HBV infection in Asian blood donors: Emphasis on occult HBV infection and the role of NAT. Journal of Clinical Virology 2006;36:S33-44. [DOI: 10.1016/s1386-6532(06)80007-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
48 Mallory MA, Page SR, Hillyard DR. Development and validation of a hepatitis B virus DNA sequencing assay for assessment of antiviral resistance, viral genotype and surface antigen mutation status. J Virol Methods 2011;177:31-7. [PMID: 21723325 DOI: 10.1016/j.jviromet.2011.06.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
49 Zheng X, Weinberger KM, Gehrke R, Isogawa M, Hilken G, Kemper T, Xu Y, Yang D, Jilg W, Roggendorf M. Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity. Virology. 2004;329:454-464. [PMID: 15518823 DOI: 10.1016/j.virol.2004.08.033] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
50 El-Zaatari M, Kazma H, Naboulsi-Majzoub M, Haidar M, Ramlawi F, Mahfoud Z, Ramia S. Hepatitis B virus DNA in serum of 'anti-HBc only'-positive healthy Lebanese blood donors: significance and possible implications. J Hosp Infect 2007;66:278-82. [PMID: 17540476 DOI: 10.1016/j.jhin.2007.04.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
51 Motta JS, Mello FC, Lago BV, Perez RM, Gomes SA, Figueiredo FF. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis. J Gastroenterol Hepatol. 2010;25:101-106. [PMID: 19817965 DOI: 10.1111/j.1440-1746.2009.05972.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
52 Perrillo R, Nair S. Hepatitis B. Zakim and Boyer's Hepatology. Elsevier; 2006. pp. 635-63. [DOI: 10.1016/b978-1-4160-3258-8.50036-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Huang CF, Dai CY, Chuang WL, Ho CK, Wu TC, Hou NJ, Wang CL, Hsieh MY, Huang JF, Lin ZY, Chen SC, Hsieh MY, Wang LY, Tsai JF, Chang WY, Yu ML. HBV infection in indigenous children, 20 years after immunization in Taiwan: a community-based study. Prev Med 2009;48:397-400. [PMID: 19463479 DOI: 10.1016/j.ypmed.2009.02.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
54 Santos EA, Yoshida CF, Rolla VC, Mendes JM, Vieira IF, Arabe J, Gomes SA. Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 2003;22:92-8. [PMID: 12627282 DOI: 10.1007/s10096-002-0868-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 2.9] [Reference Citation Analysis]
55 Neau D, Winnock M, Galpérine T, Jouvencel AC, Castéra L, Legrand E, Tranchant E, Balestre E, Lacoste D, Ragnaud JM, Dupon M, Lafon ME, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA). Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients. HIV Med 2004;5:171-3. [PMID: 15139983 DOI: 10.1111/j.1468-1293.2004.00206.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
56 Hamkar R, Aghakhani A, Soufian S, Banifazl M, Ghavami N, Nadri M, Sofian M, Ahmadi F, Razeghi E, Eslamifar A. Surface gene mutations of hepatitis B virus among high-risk patients with occult hepatitis B virus infection. Diagn Microbiol Infect Dis. 2010;66:285-291. [PMID: 19903586 DOI: 10.1016/j.diagmicrobio.2009.10.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
57 Alhababi F, Sallam TA, Tong CY. The significance of 'anti-HBc only' in the clinical virology laboratory. J Clin Virol 2003;27:162-9. [PMID: 12829038 DOI: 10.1016/s1386-6532(02)00171-3] [Cited by in Crossref: 51] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
58 Kwak MS, Kim YJ. Occult hepatitis B virus infection. World J Hepatol. 2014;6:860-869. [PMID: 25544873 DOI: 10.4254/wjh.v6.i12.860] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
59 Osborn M, Guest J, Rimland D. Hepatitis B virus and HIV coinfection: relationship of different serological patterns to survival and liver disease. HIV Med 2007;8:271-9. [DOI: 10.1111/j.1468-1293.2007.00469.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
60 Dufour DR. Liver Disease. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Elsevier; 2012. pp. 1637-93. [DOI: 10.1016/b978-1-4160-6164-9.00050-0] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
61 Scott PT, Cohen RL, Brett-Major DM, Hakre S, Malia JA, Okulicz JF, Beckett CG, Blaylock JM, Forgione MA, Harrison SA, Murray CK, Rentas FJ, Fahie RL, Armstrong AW, Hayat AM, Pacha LA, Dawson P, Blackwell B, Eick-Cost AA, Maktabi HH, Michael NL, Jagodzinski LL, Cersovsky SB, Peel SA. Hepatitis B seroprevalence in the U.S. military and its impact on potential screening strategies. Mil Med 2020;185:e1654-61. [PMID: 32648931 DOI: 10.1093/milmed/usaa131] [Reference Citation Analysis]
62 Li A, Yuan Q, Huang Z, Fan J, Guo R, Lou B, Zheng Q, Ge S, Chen Y, Su Z. Novel double-antigen sandwich immunoassay for human hepatitis B core antibody. Clin Vaccine Immunol. 2010;17:464-469. [PMID: 20107008 DOI: 10.1128/cvi.00457-09] [Cited by in Crossref: 59] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
63 Caspari G, Gerlich WH. Durch Blut übertragbare Infektionskrankheiten. In: Mueller-eckhardt C, Kiefel V, editors. Transfusionsmedizin. Berlin: Springer Berlin Heidelberg; 2004. pp. 599-645. [DOI: 10.1007/978-3-662-10597-9_36] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons. J Med Virol. 2007;79:1464-1471. [PMID: 17705185 DOI: 10.1002/jmv.20954] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
65 Schmidbauer C, Chromy D, Schmidbauer VU, Schwarz M, Jachs M, Bauer DJM, Binter T, Apata M, Nguyen DT, Mandorfer M, Simbrunner B, Rieger A, Mayer F, Breuer M, Strassl R, Schmidt R, Holzmann H, Trauner M, Gschwantler M, Reiberger T. Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients. Liver Int 2021. [PMID: 34268869 DOI: 10.1111/liv.15018] [Reference Citation Analysis]
66 Alavian SM, Carman WF, Jazayeri SM. HBsAg variants: diagnostic-escape and diagnostic dilemma. J Clin Virol. 2013;57:201-208. [PMID: 22789139 DOI: 10.1016/j.jcv.2012.04.027] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
67 Hatzakis A, Magiorkinis E, Haida C. HBV virological assessment. J Hepatol. 2006;44:S71-S76. [PMID: 16343681 DOI: 10.1016/j.jhep.2005.11.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
68 Ye YK, Zhao JH, Yan F, Zhu YL, Ju HX. Electrochemical behavior and detection of hepatitis B virus DNA PCR production at gold electrode. Biosens Bioelectron 2003;18:1501-8. [PMID: 12941566 DOI: 10.1016/s0956-5663(03)00121-0] [Cited by in Crossref: 68] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
69 Chung KM, Diamond MS. Defining the levels of secreted non-structural protein NS1 after West Nile virus infection in cell culture and mice. J Med Virol 2008;80:547-56. [PMID: 18205232 DOI: 10.1002/jmv.21091] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
70 Gessoni G, Beggio S, Barin P, Favarato M, Galli C, Valverde S, Nata MB, Salvadego MM, Marchiori G. Significance of anti-HBc only in blood donors: a serological and virological study after hepatitis B vaccination. Blood Transfus. 2014;12 Suppl 1:s63-s68. [PMID: 23522882 DOI: 10.2450/2013.0227-12] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
71 Dreier J, Kroger M, Diekmann J, Gotting C, Kleesiek K. Intermittent HBV viraemia in an anti-HBc- and anti-HBs-positive blood donor. Transfus Med 2005;15:65-6. [DOI: 10.1111/j.1365-3148.2005.00553.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
72 Sánchez Ibáñez J, Vilarrodona Serrat A, Seoane Pillado T, Rodriguez Aierbe C, Villalba Montoro R, Calvo Benito J, Pevida Lopez M, Fernández Paneque S, Vuelta Lopez E, Martínez Lorenzo MJ, González Romero M, Cañizares Castellanos A, Sauleda Oliveras S. Evaluation of occult hepatitis B infection in tissue donors: a multicenter analysis in Spain. Cell Tissue Bank 2019;20:513-26. [PMID: 31451994 DOI: 10.1007/s10561-019-09784-5] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
73 Panigrahi R, Biswas A, Datta S, Banerjee A, Chandra PK, Mahapatra PK, Patnaik B, Chakrabarti S, Chakravarty R. Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion. Virol J. 2010;7:204. [PMID: 20799931 DOI: 10.1186/1743-422x-7-204] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
74 Ramia S, Mokhbat J, Ramlawi F, El-Zaatari M. Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen. Int J STD AIDS. 2008;19:197-199. [PMID: 18397562 DOI: 10.1258/ijsa.2007.007200] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
75 Reiss G, Keeffe EB. Review article: hepatitis vaccination in patients with chronic liver disease. Aliment Pharmacol Ther. 2004;19:715-727. [PMID: 15043512 DOI: 10.1111/j.1365-2036.2004.01906.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 56] [Article Influence: 4.2] [Reference Citation Analysis]
76 Wang Q, Klenerman P, Semmo N. Significance of anti-HBc alone serological status in clinical practice. The Lancet Gastroenterology & Hepatology 2017;2:123-34. [DOI: 10.1016/s2468-1253(16)30076-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 5.3] [Reference Citation Analysis]
77 Jazayeri SM, Alavian SM, Dindoost P, Thomas HC, Karayiannis P. Molecular Variants of Hepatitis B Surface Antigen (HBsAg). In: Thomas HC, Lok AS, Locarnini SA, Zuckerman AJ, editors. Viral Hepatitis. Oxford: John Wiley & Sons, Ltd; 2013. pp. 107-26. [DOI: 10.1002/9781118637272.ch8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
78 van Roosmalen MH, de Jong JJ, Haenen W, Jacobs T, Couwenberg F, Ahlers-de Boer GJ, Hellings JA. A new HBsAg screening assay designed for sensitive detection of HBsAg subtypes and variants. Intervirology 2006;49:127-32. [PMID: 16428888 DOI: 10.1159/000089373] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
79 Taira R, Satake M, Momose S, Hino S, Suzuki Y, Murokawa H, Uchida S, Tadokoro K. Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan. Transfusion. 2013;53:1393-1404. [PMID: 23033944 DOI: 10.1111/j.1537-2995.2012.03909.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 6.8] [Reference Citation Analysis]
80 Shirani K, Nokhodian Z, Kassaian N, Adibi P, Naeini AE, Ataei B. The prevalence of isolated hepatitis B core antibody and its related risk factors among male injected drug users in Isfahan prisons. Adv Biomed Res 2015;4:17. [PMID: 25709982 DOI: 10.4103/2277-9175.148675] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
81 Valsamakis A. Molecular testing in the diagnosis and management of chronic hepatitis B. Clin Microbiol Rev. 2007;20:426-439, table of contents. [PMID: 17630333 DOI: 10.1128/cmr.00009-07] [Cited by in Crossref: 86] [Cited by in F6Publishing: 31] [Article Influence: 6.1] [Reference Citation Analysis]
82 Neau D, Winnock M, Jouvencel AC, Faure M, Castéra L, Legrand E, Lacoste D, Ragnaud JM, Dupon M, Fleury H. Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003. Clin Infect Dis. 2005;40:750-753. [PMID: 15714424 DOI: 10.1086/427882] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 2.9] [Reference Citation Analysis]
83 Berger A, Preiser W, Kachel HG, Stürmer M, Doerr HW. HBV reactivation after kidney transplantation. J Clin Virol. 2005;32:162-165. [PMID: 15653420 DOI: 10.1016/j.jcv.2004.10.006] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
84 Weber B, Dengler T, Berger A, Doerr HW, Rabenau H. Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg. J Clin Microbiol. 2003;41:135-143. [PMID: 12517838 DOI: 10.1128/jcm.41.1.135-143.2003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
85 Colomina-rodríguez J, González-garcía D, Burgos-teruel A, Fernández-lorenz N, Guerrero-espejo A. Significado de la reactividad aislada anti-HBc como único marcador de infección de la hepatitis B. Enfermedades Infecciosas y Microbiología Clínica 2005;23:80-5. [DOI: 10.1157/13071611] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
86 Weber B. Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene. Expert Rev Mol Diagn. 2005;5:75-91. [PMID: 15723594 DOI: 10.1586/14737159.5.1.75] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
87 Sagnelli E, Pisaturo M, Martini S, Filippini P, Sagnelli C, Coppola N. Clinical impact of occult hepatitis B virus infection in immuno–suppressed patients. World J Hepatol. 2014;6:384-393. [PMID: 25018849 DOI: 10.4254/wjh.v6i6.384] [Reference Citation Analysis]
88 Findik D, Arslan U, Baykan M. Determination of hepatitis B virus DNA incidence, viral load, and mutations in blood donors with HBsAg and anti-HBs-negative serology and antibodies to hepatitis B core antigen. Eur J Intern Med. 2007;18:571-575. [PMID: 18054706 DOI: 10.1016/j.ejim.2007.07.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
89 Drosten C, Nippraschk T, Manegold C, Meisel H, Brixner V, Roth W, Apedjinou A, Günther S. Prevalence of hepatitis B virus DNA in anti-HBc-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus. Journal of Clinical Virology 2004;29:59-68. [DOI: 10.1016/s1386-6532(03)00090-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
90 Sagnelli E, Pisaturo M, Martini S, Filippini P, Sagnelli C, Coppola N. Clinical impact of occult hepatitis B virus infection in immunosuppressed patients. World J Hepatol. 2014;6:384-393. [PMID: 25018849 DOI: 10.4254/wjh.v6.i6.384] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
91 Sagnelli C, Macera M, Pisaturo M, Zampino R, Coppola M, Sagnelli E. Occult HBV infection in the oncohematological setting. Infection. 2016;44:575-582. [PMID: 27076347 DOI: 10.1007/s15010-016-0891-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
92 Shahmoradi S, Yahyapour Y, Mahmoodi M, Alavian SM, Fazeli Z, Jazayeri SM. High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG. J Hepatol. 2012;57:515-521. [PMID: 22617152 DOI: 10.1016/j.jhep.2012.04.021] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 8.0] [Reference Citation Analysis]
93 Sun HY, Lee HC, Liu CE, Yang CL, Su SC, Ko WC, Lin CY, Tsai JJ, Wong WW, Ho MW, Cheng SH, Lin YH, Miao WJ, Hung CC. Factors associated with isolated anti-hepatitis B core antibody in HIV-positive patients: impact of compromised immunity. J Viral Hepat 2010;17:578-87. [PMID: 19818002 DOI: 10.1111/j.1365-2893.2009.01212.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
94 Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, Basu SK, Bhattacharya SK, Chakravarty R. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol. 2007;13:3730-3733. [PMID: 17659734 DOI: 10.3748/wjg.v13.i27.3730] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
95 Roque-Afonso AM, Ferey MP, Belkhiri D, Dussaix E. [HBs antigen mutants: prevalence, clinical and diagnostic implications]. Pathol Biol (Paris) 2005;53:563-8. [PMID: 16099111 DOI: 10.1016/j.patbio.2005.06.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
96 Deng L, Xu Y, Huang J. Developing a double-antigen sandwich ELISA for effective detection of human hepatitis B core antibody. Comparative Immunology, Microbiology and Infectious Diseases 2008;31:515-26. [DOI: 10.1016/j.cimid.2007.09.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]